ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Bristol-Myers Squibb


Include trials that are no longer recruiting patients.

17 studies were found.
1.RecruitingComparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
Condition: Hepatitis B
2.RecruitingEpothilone (ixabepilone) plus Capecitabine versus Capecitabine Alone in Patients with Advanced Breast Cancer
Conditions: Cancer; Breast Cancer
3.RecruitingEvaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Condition: Breast Cancer
4.RecruitingNavelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Condition: Breast Cancer
5.RecruitingNovel Epothilone (BMS-247550) in Patients with Metastatic Breast Cancer (MBC)
Conditions: Breast Cancer; Metastases
6.RecruitingNovel Epothilone plus Capecitabine versus Capecitabine Alone in Patients with Advanced Breast Cancer
Conditions: Breast Cancer; Metastases
7.RecruitingPhase II Study in Patients with EGFR + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Conditions: Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
8.RecruitingA Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients with Metastatic Esophageal Cancer
Condition: Esophageal Neoplasm
9.RecruitingPhase III Study of Cetuximab, Oxaliplatin, 5-FU/LV vs. Oxaliplatin, 5-FU/LV in Patients with Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
Condition: Colorectal Cancer
10.RecruitingPhase III Study of Irinotecan and Cetuximab vs Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Cancer
Condition: Colorectal Cancer
11.RecruitingSafety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
Condition: HIV Infections
12.Not yet recruitingA Study in Patients with Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
Condition: Ovarian Cancer
13.RecruitingStudy of Aripiprazole in Patients with Bipolar I Disorder with a Major Depression Episode
Condition: Bipolar Disorder
14.RecruitingA Study of Aripiprazole in Patients with Bipolar I Disorder with a Major Depressive Episode
Condition: Bipolar I Disorder
15.RecruitingStudy of Aripiprazole in Subjects with Alcoholism
Condition: Alcoholism
16.RecruitingStudy of Erbitux (cetuximab) Given Alone to Patients with EGFR-undetectable Metastatic Colon or Rectal Cancer that is Refractory to Chemotherapy
Conditions: Colorectal Neoplasms; Metastases; Neoplasm
17.RecruitingTandem cycles of high dose chemotherapy followed by stem cell support for ovarian cancer
Condition: Ovarian Neoplasms

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act